APOD and myeloid sarcoma: In conclusion, this work reinforces the neuroprotective role of Apo D in the context of myelin dynamics and demyelinating pathology, providing a solid foundation for future studies aimed at identifying novel therapeutic targets, particularly for progressive forms of MS and related disorders.